Lisinopril and Hydrochlorothiazide
- Product NDC
- 70518-0139
- 11-digit product format
- 705180139
- Labeler code
- 70518
- Product ID
- 70518-0139_df4b01f4-87d5-cfc0-e053-2995a90a1ee6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA076194
- Marketing category
- ANDA
- Marketing start
- 2017-01-18
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE; LISINOPRIL
- Active strength
- 13 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-0139-0 | 70518013900 | 90 TABLET in 1 BOTTLE (70518-0139-0) | 90 tablet | 2017-01-18 | 0000-00-00 | No | No | Current |
| 70518-0139-2 | 70518013902 | 30 TABLET in 1 BLISTER PACK (70518-0139-2) | 30 tablet | 2020-03-25 | 0000-00-00 | No | No | Current |